# Filing Detail

Form DRS - Draft Registration Statement:
SEC Accession No. 0001104659-21-065999
Filing Date
2021-05-13
Accepted
2021-05-13 16:57:10
Documents
56

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS | 2735249
2 |  | filename2.htm | EX-10.1 | 353015
3 |  | filename3.htm | EX-10.2 | 83073
4 |  | filename4.htm | EX-10.5 | 94103
5 |  | filename5.htm | EX-10.6 | 72255
6 |  | filename6.htm | EX-10.7 | 78021
7 | GRAPHIC | tm2115679d2_ex99-1img001.jpg | GRAPHIC | 54299
8 | GRAPHIC | lg_immuneering-4clr.jpg | GRAPHIC | 19671
9 | GRAPHIC | tm2115679d1-tbl_cancer4c.jpg | GRAPHIC | 215156
10 | GRAPHIC | tm2115679d1-lc_tradtion4c.jpg | GRAPHIC | 110814
11 | GRAPHIC | tm2115679d1-fc_discovery4c.jpg | GRAPHIC | 112568
12 | GRAPHIC | tm2115679d1-tbl_phospho4clr.jpg | GRAPHIC | 121340
13 | GRAPHIC | tm2115679d1-fc_prop4c.jpg | GRAPHIC | 185888
14 | GRAPHIC | tm2115679d1-tbl_target4c.jpg | GRAPHIC | 172387
15 | GRAPHIC | tm2115679d1-tbl_pipeline4c.jpg | GRAPHIC | 81796
16 | GRAPHIC | tm2115679d1-fc_highly4c.jpg | GRAPHIC | 82656
17 | GRAPHIC | tm2115679d1-bc_tumor4c.jpg | GRAPHIC | 153144
18 | GRAPHIC | tm2115679d1-bc_comparisn4c.jpg | GRAPHIC | 99734
19 | GRAPHIC | tm2115679d1-lc_selumet4c.jpg | GRAPHIC | 157377
20 | GRAPHIC | tm2115679d1-lc_immbini4c.jpg | GRAPHIC | 175542
21 | GRAPHIC | tm2115679d1-lc_imm1bin4c.jpg | GRAPHIC | 169435
22 | GRAPHIC | tm2115679d1-lc_kras4clr.jpg | GRAPHIC | 121993
23 | GRAPHIC | tm2115679d1-lc_nras4clr.jpg | GRAPHIC | 129386
24 | GRAPHIC | tm2115679d1-lc_amgimm4c.jpg | GRAPHIC | 192404
25 | GRAPHIC | tm2115679d1-lc_imm1044c.jpg | GRAPHIC | 214344
26 | GRAPHIC | tm2115679d1-tbl_a549tum4c.jpg | GRAPHIC | 123056
27 | GRAPHIC | tm2115679d1-tbl_a375tum4c.jpg | GRAPHIC | 62168
28 | GRAPHIC | tm2115679d1-fc_brain4clr.jpg | GRAPHIC | 144286
29 | GRAPHIC | tm2115679d1-fc_recursi4clr.jpg | GRAPHIC | 77845
30 | GRAPHIC | tm2115679d1-fc_neurosc4c.jpg | GRAPHIC | 47510
31 | GRAPHIC | tm2115679d1-bc_vitro4c.jpg | GRAPHIC | 46704
32 | GRAPHIC | tm2115679d1-bc_fluency4c.jpg | GRAPHIC | 68969
33 | GRAPHIC | tm2115679d1-bc_micro4c.jpg | GRAPHIC | 89658
34 | GRAPHIC | tm2115679d1-lc_gene4c.jpg | GRAPHIC | 125372
35 | GRAPHIC | tm2115679d1-fc_compou4clr.jpg | GRAPHIC | 64521
36 | GRAPHIC | tm2115679d1-ph_fluen4clr.jpg | GRAPHIC | 109540
37 | GRAPHIC | tm2115679d1-lc_erbb24c.jpg | GRAPHIC | 103071
38 | GRAPHIC | tm2115679d2_ex10-5img001.jpg | GRAPHIC | 12217
39 | GRAPHIC | tm2115679d2_ex10-5img002.jpg | GRAPHIC | 1210
40 | GRAPHIC | tm2115679d2_ex10-5img003.jpg | GRAPHIC | 1210
41 | GRAPHIC | tm2115679d2_ex10-5img004.jpg | GRAPHIC | 1210
42 | GRAPHIC | tm2115679d2_ex10-5img005.jpg | GRAPHIC | 1210
43 | GRAPHIC | tm2115679d2_ex10-5img007.jpg | GRAPHIC | 1210
44 | GRAPHIC | tm2115679d2_ex10-5img008.jpg | GRAPHIC | 1210
45 | GRAPHIC | tm2115679d2img_007.jpg | GRAPHIC | 1017
46 | GRAPHIC | tm2115679d2img_006.jpg | GRAPHIC | 1017
47 | GRAPHIC | tm2115679d2img_005.jpg | GRAPHIC | 1017
48 | GRAPHIC | tm2115679d2img_004.jpg | GRAPHIC | 1017
49 | GRAPHIC | tm2115679d2img_003.jpg | GRAPHIC | 1017
50 | GRAPHIC | tm2115679d2img_002.jpg | GRAPHIC | 1017
51 | GRAPHIC | tm2115679d2_ex10-5img03.jpg | GRAPHIC | 4704
52 | GRAPHIC | tm2115679d2_img4.jpg | GRAPHIC | 4521
53 | GRAPHIC | tm2115679d2_img5.jpg | GRAPHIC | 1148
54 | GRAPHIC | image_003.jpg | GRAPHIC | 16210
55 | GRAPHIC | image_004.jpg | GRAPHIC | 13918
56 | GRAPHIC | image_006.jpg | GRAPHIC | 1173
| Complete submission text file | 0001104659-21-065999.txt |  | 8511236

Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-04858 | Film No.: 21920510
SIC: 2834 Pharmaceutical Preparations